Nektar Therapeutics (NKTR) EBIAT (2010 - 2026)
Nektar Therapeutics' quarterly EBIAT came in at -$44.9 million in Q1 2026, up 11.75% year-on-year from -$40.2 million in Q1 2025, and down 24.46% quarter-over-quarter from -$36.1 million in Q4 2025.
Nektar Therapeutics has reported EBIAT for 17 years, with the latest figure at -$44.9 million in Q1 2026.
- For the quarter ending Q1 2026, EBIAT rose 11.75% year-over-year to -$44.9 million; the trailing twelve-month figure through Mar 2026 stood at -$158.1 million (down 18.83% YoY), and the FY2025 full-year result was -$164.1 million, down 37.92% from the prior year.
- EBIAT for Q1 2026 stood at -$44.9 million, down from -$36.1 million in the prior quarter.
- The five-year high for EBIAT was $7.3 million in Q4 2024, with the low at -$159.1 million in Q2 2022.
- Average EBIAT over 5 years is -$57.2 million, with a median of -$45.8 million recorded in 2023.
- Year-over-year, EBIAT jumped 117.26% in 2024 and plunged 596.89% in 2025.
- Tracing NKTR's EBIAT over 5 years: stood at -$59.7 million in 2022, then grew by 29.5% to -$42.1 million in 2023, then surged by 117.26% to $7.3 million in 2024, then sank by 596.89% to -$36.1 million in 2025, then decreased by 24.46% to -$44.9 million in 2026.
- The last three EBIAT figures came in at -$44.9 million (Q1 2026), -$36.1 million (Q4 2025), and -$35.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Nektar Therapeutics | 1.60 Bn | 1.04 Bn | 3.16 Mn | -44.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.90 Mn |
| Dec 31, 2025 | -36.08 Mn |
| Sep 30, 2025 | -35.52 Mn |
| Jun 30, 2025 | -41.59 Mn |
| Mar 31, 2025 | -50.88 Mn |
| Dec 31, 2024 | 7.26 Mn |
| Sep 30, 2024 | -37.06 Mn |
| Jun 30, 2024 | -52.36 Mn |
| Mar 31, 2024 | -36.80 Mn |
| Dec 31, 2023 | -42.08 Mn |
| Sep 30, 2023 | -45.84 Mn |
| Jun 30, 2023 | -51.12 Mn |
| Mar 31, 2023 | -137.02 Mn |
| Dec 31, 2022 | -59.69 Mn |
| Sep 30, 2022 | -59.05 Mn |
| Jun 30, 2022 | -159.07 Mn |
| Mar 31, 2022 | -90.39 Mn |
| Dec 31, 2021 | -145.65 Mn |
| Sep 30, 2021 | -129.71 Mn |
| Jun 30, 2021 | -125.52 Mn |
| Mar 31, 2021 | -122.97 Mn |
| Dec 31, 2020 | -117.20 Mn |
| Sep 30, 2020 | -108.59 Mn |
| Jun 30, 2020 | -80.00 Mn |
| Mar 31, 2020 | -138.65 Mn |
| Dec 31, 2019 | -112.16 Mn |
| Sep 30, 2019 | -98.59 Mn |
| Jun 30, 2019 | -110.29 Mn |
| Mar 31, 2019 | -119.63 Mn |
| Dec 31, 2018 | -98.21 Mn |
| Sep 30, 2018 | -96.14 Mn |
| Jun 30, 2018 | 971.46 Mn |
| Mar 31, 2018 | -95.79 Mn |
| Dec 31, 2017 | -33.83 Mn |
| Sep 30, 2017 | 60.87 Mn |
| Jun 30, 2017 | -59.87 Mn |
| Mar 31, 2017 | -63.87 Mn |
| Dec 31, 2016 | -42.20 Mn |
| Sep 30, 2016 | -43.22 Mn |
| Jun 30, 2016 | -48.60 Mn |
| Mar 31, 2016 | -19.50 Mn |
| Dec 31, 2015 | -54.14 Mn |
| Sep 30, 2015 | -8.20 Mn |
| Jun 30, 2015 | -52.66 Mn |
| Mar 31, 2015 | 33.82 Mn |
| Dec 31, 2014 | -45.68 Mn |
| Sep 30, 2014 | 70.61 Mn |
| Jun 30, 2014 | -32.64 Mn |
| Mar 31, 2014 | -46.20 Mn |
| Dec 31, 2013 | -47.66 Mn |
| Sep 30, 2013 | -16.54 Mn |
| Jun 30, 2013 | -42.75 Mn |
| Mar 31, 2013 | -55.06 Mn |
| Dec 31, 2012 | -52.93 Mn |
| Sep 30, 2012 | -43.55 Mn |
| Jun 30, 2012 | -34.29 Mn |
| Mar 31, 2012 | -41.10 Mn |
| Dec 31, 2011 | -37.50 Mn |
| Sep 30, 2011 | -24.07 Mn |
| Jun 30, 2011 | -36.38 Mn |
| Mar 31, 2011 | -36.03 Mn |
| Dec 31, 2010 | -22.58 Mn |
| Sep 30, 2010 | -8.71 Mn |
| Jun 30, 2010 | -517,000.00 |
| Mar 31, 2010 | -6.13 Mn |